BJS Open最新文献

筛选
英文 中文
Role of sentinel lymph node biopsy in patients with early breast cancer undergoing mastectomy. 前哨淋巴结活检在早期乳腺癌乳房切除术中的作用。
IF 4.9 3区 医学
BJS Open Pub Date : 2026-09-04 DOI: 10.1093/bjsopen/zrag105
Martin Heidinger, Giacomo Montagna, Florian S Halbeisen, Anna-Lena Eberhardt, Nadia Maggi, Marie Louise Frevert, Karol Dollt, Rama Kiblawi, Julie M Loesch, Jelena Winkler, Fabienne D Schwab, Christian Kurzeder, Tibor A Zwimpfer, Walter P Weber
{"title":"Role of sentinel lymph node biopsy in patients with early breast cancer undergoing mastectomy.","authors":"Martin Heidinger, Giacomo Montagna, Florian S Halbeisen, Anna-Lena Eberhardt, Nadia Maggi, Marie Louise Frevert, Karol Dollt, Rama Kiblawi, Julie M Loesch, Jelena Winkler, Fabienne D Schwab, Christian Kurzeder, Tibor A Zwimpfer, Walter P Weber","doi":"10.1093/bjsopen/zrag105","DOIUrl":"10.1093/bjsopen/zrag105","url":null,"abstract":"<p><strong>Background: </strong>The oncological non-inferiority of sentinel lymph node biopsy omission in patients with small, clinically and imaging node-negative (cN0/iN0) breast cancer has been demonstrated for patients undergoing breast-conserving surgery and adjuvant radiotherapy, but not for those undergoing mastectomy. This single-centre, retrospective cohort study compared nodal involvement and adjuvant therapy indications in these patients by use of mastectomy versus breast-conserving surgery.</p><p><strong>Methods: </strong>Patients with cT1-T2, cN0/iN0, hormone receptor-positive/human epidermal growth factor receptor 2-negative early breast cancer who underwent upfront surgery including sentinel lymph node biopsy between January 2014 and December 2024 were included. Adjuvant therapy indications were estimated using monarchE (abemaciclib), NATALEE (ribociclib), TAILORx and RxPONDER (chemotherapy), and MA.20 and EORTC22922/10925 (nodal irradiation) eligibility criteria. Multivariable logistic regression models identified factors associated with nodal involvement and adjuvant treatment indications.</p><p><strong>Results: </strong>Among 454 patients, 145 (31.9%) underwent mastectomy who more frequently had multifocal tumours (23.5% versus 9.7%), lobular subtype (21.4% versus 11.3%), and grade 2-3 differentiation (73.8% versus 63.8%) compared with those who underwent breast-conserving surgery. Neither nodal involvement (18.6% versus 14.9%; P = 0.149) nor missed indications for adjuvant abemaciclib (7.6% versus 6.1%; P = 0.550), ribociclib (9.7% versus 7.8%; P = 0.586), and nodal irradiation (4.8% versus 4.5%; P = 1.000) differed between patients who underwent mastectomy or breast-conserving surgery. Lymphovascular invasion was independently associated with nodal involvement (odds ratio 6.8, 95% confidence interval 3.7 to 12.8; P < 0.001) and adjuvant treatment indications (CDK4/6 inhibitors: odds ratio 5.1, 2.6 to 10.1; P < 0.001; nodal irradiation: odds ratio 7.1, 3.6 to 14.4; P < 0.001), whereas type of surgery was not.</p><p><strong>Conclusions: </strong>In patients with cT1-T2, cN0/iN0, hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer, type of breast surgery was not associated with nodal involvement and adjuvant therapy.</p>","PeriodicalId":9028,"journal":{"name":"BJS Open","volume":"10 5","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13542998/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148890997","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predicting postoperative acute kidney injury after colorectal cancer surgery: development and internal validation of a clinical prediction model using a nationwide cohort. 预测结直肠癌手术后急性肾损伤:使用全国队列的临床预测模型的开发和内部验证
IF 4.9 3区 医学
BJS Open Pub Date : 2026-09-04 DOI: 10.1093/bjsopen/zrag124
Mads Skovsgaard, Philip V Munch, Uffe Heide-Jørgensen, Lene H Iversen, Christian F Christiansen
{"title":"Predicting postoperative acute kidney injury after colorectal cancer surgery: development and internal validation of a clinical prediction model using a nationwide cohort.","authors":"Mads Skovsgaard, Philip V Munch, Uffe Heide-Jørgensen, Lene H Iversen, Christian F Christiansen","doi":"10.1093/bjsopen/zrag124","DOIUrl":"10.1093/bjsopen/zrag124","url":null,"abstract":"<p><strong>Background: </strong>Postoperative acute kidney injury (PO-AKI) occurs in 8-20% of patients undergoing colorectal cancer surgery and is associated with increased mortality and morbidity. A prediction model can help in the identification of high-risk patients and guide clinicians in implementing preventive measures. The present study aimed to develop and validate internally a clinical prediction model for the risk of PO-AKI within 7 days after an elective resection of colorectal cancer, using predictors known before surgery.</p><p><strong>Methods: </strong>Using a nationwide clinical quality database, all patients with stage I-IV colorectal cancer undergoing an elective colorectal resection from 2015 to 2021 in Denmark were identified. Patient characteristics, comorbidities, medications, and laboratory values were obtained through linkage across national health registries. The outcome was PO-AKI within 7 days after surgery, defined according to the Kidney Disease Improving Global Outcomes criteria. A logistic regression model was fitted using preoperative predictors, backward selection was applied to derive the final model, and internal validation was performed through two-fold bootstrapping. The performance was assessed using discrimination and calibration measures.</p><p><strong>Results: </strong>Among 26 104 identified patients, 20 277 patients were included, and 1747 (8.6%) developed AKI within 7 days. Fifty-four per cent were men, and the median age was 71 years (interquartile range, 64-78 years). The final model included 14 preoperative predictors. The model showed moderate discriminative performance with an optimism-corrected c-statistic of 0.70 (95% confidence interval 0.68 to 0.71) and was well calibrated at PO-AKI risks between 0% and 20% but somewhat overestimated higher risks (overall slope 0.95; intercept -0.001). The prediction model is available as a calculator at https://po-aki.streamlit.app.</p><p><strong>Conclusion: </strong>The model predicted PO-AKI with moderate accuracy and may support the implementation of preventive measures. However, external validation is required to confirm its applicability.</p>","PeriodicalId":9028,"journal":{"name":"BJS Open","volume":"10 5","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13555295/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148910767","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multiple R1 margins are associated with shorter overall survival: national register-based study on pancreatic cancer. 多个R1切缘与较短的总生存期相关:基于国家登记的胰腺癌研究
IF 4.9 3区 医学
BJS Open Pub Date : 2026-09-04 DOI: 10.1093/bjsopen/zrag155
Patrik Larsson, Carlos Fernández Moro, Melroy D'Souza, Bobby Tingstedt, Ernesto Sparrelid, Poya Ghorbani
{"title":"Multiple R1 margins are associated with shorter overall survival: national register-based study on pancreatic cancer.","authors":"Patrik Larsson, Carlos Fernández Moro, Melroy D'Souza, Bobby Tingstedt, Ernesto Sparrelid, Poya Ghorbani","doi":"10.1093/bjsopen/zrag155","DOIUrl":"10.1093/bjsopen/zrag155","url":null,"abstract":"<p><strong>Background: </strong>Resection status is associated with overall survival among patients operated on for pancreatic ductal adenocarcinoma (PDAC). This study investigated whether the number of R1 margins is associated with shorter survival.</p><p><strong>Methods: </strong>Adult patients who underwent pancreatoduodenectomy for primary resectable PDAC between 2017 and 2024 recorded in the Swedish National Pancreatic Registry were included. Overall survival was analysed according to overall R status and the number of R1 margins. Overall survival was analysed using Kaplan-Meier estimates, Cox regression analysis for estimated adjusted survival time, and Laplace regression for analysis of percentile distribution.</p><p><strong>Results: </strong>Overall, 1043 patients were included, 398 patients (38.2%) with R0 and 645 patients (61.8%) with R1 margins. The adjusted median survival was 8.2 (95% confidence interval (c.i.) -12.0 to -4.3) months shorter for patients with R1 versus R0 margins, with a progressively shorter survival with a higher number of R1 margins. Specifically, compared with R0 margins, the adjusted median survival for one, two and three or more R1 margins was 4.6 (95% c.i. -10.2 to 1.0), 6.7 (95% c.i. -11.9 to -1.5), and 12.4 (95% c.i. -16.5 to -8.3) months shorter, respectively.</p><p><strong>Conclusions: </strong>Patients with R1 margins had an adjusted median survival that was 8 months shorter than patients with R0 margins. An increased number of R1 margins was associated with shorter survival. These results suggest that the current practice of reporting binary R status is insufficient, and future guidelines should consider revising this routine and adopt a standardized, detailed margin assessment protocol.</p>","PeriodicalId":9028,"journal":{"name":"BJS Open","volume":"10 5","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13675251/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149206564","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Novel algorithm for the diagnosis and treatment of different types of bile leakage following liver surgery. 肝脏手术后不同类型胆漏诊断与治疗的新算法。
IF 4.9 3区 医学
BJS Open Pub Date : 2026-09-04 DOI: 10.1093/bjsopen/zrag110
Sepehr Abbasi Dezfouli, Elmira Heidenreich, Mohammadamin Shahrbaf, Elias Khajeh, Ali Ramouz, Miriam Klauss, Katharina Hellbach, Osman Öcal, Martin Loos, Arianeb Mehrabi
{"title":"Novel algorithm for the diagnosis and treatment of different types of bile leakage following liver surgery.","authors":"Sepehr Abbasi Dezfouli, Elmira Heidenreich, Mohammadamin Shahrbaf, Elias Khajeh, Ali Ramouz, Miriam Klauss, Katharina Hellbach, Osman Öcal, Martin Loos, Arianeb Mehrabi","doi":"10.1093/bjsopen/zrag110","DOIUrl":"https://doi.org/10.1093/bjsopen/zrag110","url":null,"abstract":"<p><strong>Background: </strong>Posthepatectomy bile leakage (PHBL) after liver resection with bilioenteric anastomosis may originate from the anastomosis (anastomotic leak (AL)) or the transection surface (surface leak), including leakage from isolated bile ducts (IBDLs). Differentiating these sources remains challenging, and standardized management guidelines are lacking.</p><p><strong>Methods: </strong>All patients undergoing liver resection with bilioenteric anastomosis from 2008-2023 were analysed. PHBL was classified by origin (AL, surface leak, IBDL) and timing (early versus late onset). Drain fluid bilirubin concentration, drain-to-serum bilirubin ratio, and daily bilirubin loss were evaluated by leak type. Outcomes of conservative, interventional, and surgical management were compared.</p><p><strong>Results: </strong>Among 2936 liver resections, 229 involved bilioenteric anastomosis. PHBL occurred in 96 patients, including 44 ALs (46%), 47 surface leaks (49%), and 5 IBDLs (5%). AL showed higher peak drain bilirubin than surface leak/IBDL (38.3 versus 18.6 mg/dl; P < 0.001). Receiver operating characteristic analysis identified cut-offs for AL diagnosis: drain bilirubin > 20.85 mg/dl, drain-to-serum ratio > 10.57, and bilirubin loss > 160.93 mg/day. Management success varied by type and timing: AL and IBDL responded best to reoperation (success rates 78% and 100%), whereas surface leak was more effectively managed without surgery (65%). In AL specifically, reoperation was more successful in early-onset leaks (65% versus 38% in late-onset; P = 0.069), whereas interventional therapy was more successful in late-onset leaks (58% versus 15% in early-onset; P = 0.003).</p><p><strong>Conclusions: </strong>Distinct diagnostic thresholds help differentiate AL from other PHBL types. AL and IBDL benefit from reoperation, whereas surface leak is better managed without surgery. Timing influences therapeutic success, supporting a novel type- and timing-based management algorithm for PHBL.</p>","PeriodicalId":9028,"journal":{"name":"BJS Open","volume":"10 5","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13711662/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149285061","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictors of morbidity and oncological benefit after liver resection with vascular reconstruction: international collaborative study from expert centres. 肝切除血管重建后发病率和肿瘤获益的预测因素:来自专家中心的国际合作研究。
IF 4.9 3区 医学
BJS Open Pub Date : 2026-09-04 DOI: 10.1093/bjsopen/zrag085
Victor Lopez-Lopez, Francesca Ratti, Cecilia Maina, Juan Gonzalez-Ferez, Sarah Daniels, Nikhil Suresh, Safi Dokmak, Elias Karam, Augustin Suffisseu, Yawen Dong, Zhihao Li, Rory L Smoot, Muhammad Ahmad Nadeem, Federico Aucejo, Emilio Vicente, Enrico Gringeri, Eleonora Nieddu, Jordi Navinés, Lucia Hernandez, Mohammad H Fard-Aghaie, Jens Rolinger, Leyre Serrablo, Sanjay Govil, William Archie, Dionisios Vrochides, Martin de Santibañes, Eduardo de Santibañes, Fabrizio Di Benedetto, Silvio M P Balzan, Cristina Dopazo, Vicente Borrego Estella, Giuseppe Kito Fusai, Fernando Rotellar Sastre, Roberto I Troisi, Alejandro Serrablo, Silvio Nadalin, Karl J Oldhafer, Esteban Cugat, Umberto Cillo, Andrea Schlegel, Patrick Starlinger, Mickael Lesurtel, Luca Aldrighetti, Pierre Alain Clavien, Daniel Azoulay, Peter Lodge, Ricardo Robles Campos
{"title":"Predictors of morbidity and oncological benefit after liver resection with vascular reconstruction: international collaborative study from expert centres.","authors":"Victor Lopez-Lopez, Francesca Ratti, Cecilia Maina, Juan Gonzalez-Ferez, Sarah Daniels, Nikhil Suresh, Safi Dokmak, Elias Karam, Augustin Suffisseu, Yawen Dong, Zhihao Li, Rory L Smoot, Muhammad Ahmad Nadeem, Federico Aucejo, Emilio Vicente, Enrico Gringeri, Eleonora Nieddu, Jordi Navinés, Lucia Hernandez, Mohammad H Fard-Aghaie, Jens Rolinger, Leyre Serrablo, Sanjay Govil, William Archie, Dionisios Vrochides, Martin de Santibañes, Eduardo de Santibañes, Fabrizio Di Benedetto, Silvio M P Balzan, Cristina Dopazo, Vicente Borrego Estella, Giuseppe Kito Fusai, Fernando Rotellar Sastre, Roberto I Troisi, Alejandro Serrablo, Silvio Nadalin, Karl J Oldhafer, Esteban Cugat, Umberto Cillo, Andrea Schlegel, Patrick Starlinger, Mickael Lesurtel, Luca Aldrighetti, Pierre Alain Clavien, Daniel Azoulay, Peter Lodge, Ricardo Robles Campos","doi":"10.1093/bjsopen/zrag085","DOIUrl":"10.1093/bjsopen/zrag085","url":null,"abstract":"<p><strong>Background: </strong>Liver resection with vascular reconstruction is a highly complex procedure for advanced hepatobiliary tumours. This study evaluated the postoperative and oncological outcomes of this patient cohort.</p><p><strong>Methods: </strong>This retrospective multicentre study included patients undergoing liver resection with vascular reconstruction between 1990 and 2024 across 21 expert centres. Reconstructions involved the inferior vena cava, hepatic veins, portal vein, or hepatic artery. Primary endpoints were postoperative morbidity and 90-day mortality. Secondary endpoints included overall survival (OS), disease-free survival (DFS), and predictors of complications. Multivariable logistic regression, Kaplan-Meier, and Fine-Gray analyses were performed.</p><p><strong>Results: </strong>In all, 532 patients were included and classified according to surgical approach as in situ (455, 85.3%), ante situm (48, 9.2%), or ex situ (29, 5.5%). The most frequent indications were colorectal liver metastases (162, 30.4%), intrahepatic cholangiocarcinoma (139, 26.1%), and perihilar cholangiocarcinoma (106, 19.9%). The median operative time was 390 minutes. Clavien-Dindo ≥ IIIa occurred in 217 patients (40.8%), and the 90-day mortality rate was 9.8% (52). Portal vein reconstruction independently predicted post-hepatectomy liver failure, ascites, infectious complications, and major morbidity, whereas inferior vena cava reconstruction showed a more favourable perioperative profile. Hepatic vein reconstruction was associated with greater transfusion requirements and longer operative time. Vascular graft-related complications occurred in 22.3% (58) of reconstructions and were not associated with graft type. After excluding patients with perihilar cholangiocarcinoma (426), ante situm and ex situ procedures were associated with higher rates of Clavien-Dindo ≥ IIIa than in situ procedures (67.3% (33) and 64.3% (18) versus 35.5% (124), respectively; P < 0.001), longer intensive care unit stay (6.5 and 5 versus 3 days, respectively; P < 0.001), and higher mortality (16.3% (8) and 17.9% (5) versus 8.3% (29), respectively; P = 0.060). DFS was superior for hepatocellular carcinoma (P = 0.011), whereas perihilar cholangiocarcinoma showed a higher risk of recurrence (P = 0.022). Five-year OS was highest for sarcoma (68.8%) and hepatocellular carcinoma (42.7%).</p><p><strong>Conclusion: </strong>Liver resection with vascular reconstruction is feasible in specialized centres but remains associated with substantial morbidity and mortality. The in situ approach showed the most favourable perioperative outcomes, although oncological benefit varied according to tumour biology, highlighting the importance of careful patient selection.</p>","PeriodicalId":9028,"journal":{"name":"BJS Open","volume":"10 5","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13617666/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149069293","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Methodological challenges in surgical randomized trials: systematic review of rectal cancer studies. 外科随机试验的方法学挑战:直肠癌研究的系统回顾。
IF 4.9 3区 医学
BJS Open Pub Date : 2026-09-04 DOI: 10.1093/bjsopen/zrag102
Daichi Kitaguchi, Mariano Giménez, Antonello Forgione, Tatsuya Oda, Jacques Marescaux
{"title":"Methodological challenges in surgical randomized trials: systematic review of rectal cancer studies.","authors":"Daichi Kitaguchi, Mariano Giménez, Antonello Forgione, Tatsuya Oda, Jacques Marescaux","doi":"10.1093/bjsopen/zrag102","DOIUrl":"10.1093/bjsopen/zrag102","url":null,"abstract":"<p><strong>Background: </strong>Surgical randomized clinical trials (RCTs) have structural features that differ fundamentally from those of non-surgical trials, which may complicate appraisal using standard assessment frameworks. This methodological systematic review used rectal cancer surgery RCTs as a high-complexity exemplar to identify surgically specific methodological challenges and to examine their interaction with established tools for assessing risk of bias and certainty of evidence.</p><p><strong>Methods: </strong>A systematic literature search was conducted in PubMed, Embase, and the Cochrane Library on 1 November 2025. Eligible studies were RCTs evaluating surgery-related interventions for rectal cancer in adult patients, published in English from 2020 onward, with sufficient methodological detail. Included trials were categorized into predefined, mutually exclusive surgical RCT types. Methodological features were descriptively summarized and conceptually mapped to the domains of the revised Cochrane Risk of Bias (RoB 2) tool and the GRADE framework using both quantitative tabulation and narrative synthesis.</p><p><strong>Results: </strong>Of 1529 records identified, 45 publications reporting on 35 RCTs were included. Trials were classified into five surgical RCT categories. Surgically specific methodological challenges were most frequently observed in RoB 2 domains D2 (bias due to deviations from intended interventions) and D4 (bias in measurement of the outcome), as well as in the GRADE domain of indirectness.</p><p><strong>Conclusion: </strong>This review suggests that several challenges encountered when applying RoB 2 and GRADE to surgical RCTs arise from structural characteristics of surgical trial design rather than obvious methodological shortcomings. Contextualizing standard appraisal frameworks within the realities of surgical research may allow for a more nuanced interpretation of existing evidence, inform future trial design, and support more appropriate evidence synthesis.</p>","PeriodicalId":9028,"journal":{"name":"BJS Open","volume":"10 5","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13591274/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149011878","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Measures of physical fitness and postoperative mortality in patients with colorectal cancer: national cohort study. 结直肠癌患者身体健康和术后死亡率的测量:国家队列研究。
IF 4.9 3区 医学
BJS Open Pub Date : 2026-09-04 DOI: 10.1093/bjsopen/zrag130
Adil Rashid, Helen A Blake, Leo Watton, Nicola S Fearnhead, Lu Han, Jan van der Meulen, Kate Walker
{"title":"Measures of physical fitness and postoperative mortality in patients with colorectal cancer: national cohort study.","authors":"Adil Rashid, Helen A Blake, Leo Watton, Nicola S Fearnhead, Lu Han, Jan van der Meulen, Kate Walker","doi":"10.1093/bjsopen/zrag130","DOIUrl":"https://doi.org/10.1093/bjsopen/zrag130","url":null,"abstract":"<p><strong>Background: </strong>Measures of physical fitness are essential for case mix adjustment when comparing surgical outcomes between patient groups, surgical approaches, and healthcare providers. Commonly used measures include clinician-reported American Society of Anesthesiologists (ASA) grade and Eastern Cooperative Oncology Group (ECOG) performance status, as well as the Secondary Care Administrative Records Frailty (SCARF) index, derived from routinely collected administrative hospital data. This study compared how these measures of physical fitness, perform for case mix adjustment of postoperative colorectal cancer mortality.</p><p><strong>Methods: </strong>All patients diagnosed with colorectal cancer (CRC) between April 2017 and March 2022 in the English and Welsh National Health Service who underwent surgery were included. The primary outcome was 90-day postoperative mortality. Using an established risk-adjustment model, different combinations of ASA grade, performance status, and the SCARF index were added to create eight models for 90-day mortality risk adjustment. Model performance was compared with a full model including all three measures of physical fitness. The basic model included no measures of physical fitness. The scaled Brier score (SBS) measured overall model performance and the C-statistic measured discriminatory ability.</p><p><strong>Results: </strong>Among 91 957 patients, 90-day mortality was 2.8%. A model including both ASA grade and performance status achieved equivalent performance (SBS 0.092; C-statistic 0.833 (95% confidence interval (c.i.) 0.825 to 0.841)) to the full model (SBS 0.092; C-statistic 0.834 (95% c.i. 0.827 to 0.842)). The basic model with only performance status was slightly inferior (SBS 0.076; C-statistic 0.822 (95% c.i. 0.814 to 0.830)) to the basic model with only ASA grade (SBS 0.084; C-statistic 0.827 (95% c.i. 0.819 to 0.835)).</p><p><strong>Conclusion: </strong>Performance status and ASA grade together accurately adjust for physical fitness when risk adjusting postoperative mortality in patients with CRC. When only one measure is available, performance status or ASA grade alone is suitable to support risk-adjusted hospital benchmarking.</p>","PeriodicalId":9028,"journal":{"name":"BJS Open","volume":"10 5","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13692692/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149262351","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Short-term outcomes after major lower limb amputation: meta-analysis. 下肢截肢后的短期结果:荟萃分析。
IF 4.9 3区 医学
BJS Open Pub Date : 2026-09-04 DOI: 10.1093/bjsopen/zrag122
Nick Moody, Rhiannon Nielsen, Megan Lyons, Leanne Murphy, Becky Sandford, David C Bosanquet, Kathryn Chu, Matthew Popplewell, Justine Davies
{"title":"Short-term outcomes after major lower limb amputation: meta-analysis.","authors":"Nick Moody, Rhiannon Nielsen, Megan Lyons, Leanne Murphy, Becky Sandford, David C Bosanquet, Kathryn Chu, Matthew Popplewell, Justine Davies","doi":"10.1093/bjsopen/zrag122","DOIUrl":"10.1093/bjsopen/zrag122","url":null,"abstract":"<p><strong>Introduction: </strong>Mortality after major lower limb amputation is a key factor in the decision to perform surgery. This review synthesizes the evidence on in-hospital and 30-day postoperative mortality after major amputation.</p><p><strong>Methods: </strong>Electronic databases Medline, Embase, Scopus and African Journals Online were searched using keywords and thesaurus terms in October 2024 and updated in November 2025. Studies published globally and reporting in-hospital or 30-day mortality after major lower limb amputation (defined as at- or above-ankle amputation, or transtibial amputation (TTA) and/or transfemoral amputation (TFA)) and published between 2008 and 2025 were included. Only population level studies were included. Meta-analysis was performed and prediction intervals used to report findings primarily. The Newcastle-Ottawa tool was used to assess the methodological quality of studies.</p><p><strong>Results: </strong>Fifty-two studies were included (1 067 616 patients). Only three studies were from low- and middle-income countries (two from Brazil, one from Togo). Most studies were either from North America (42%) or Europe and Central Asia (36%). Twenty-six studies reported in-hospital mortality and 26 reported 30-day mortality. Prediction intervals were 3.6-24.5% (point estimate 10.0%, 95% confidence interval 8.2% to 12.1%; 664 608), and 4.0-20.4% (point estimate 9.4%, 8.0% to 11.0%; 390 030) for in-hospital and 30-day mortality, respectively. In-hospital mortality prediction intervals were 2.9-12.7% (point estimate 6.2%, 5.1% to 7.7%; 77 204) for TTAs and 5.6-23.3% (point estimate: 11.8%, 9.6% to 14.4%; 78 632) for TFAs. Prediction intervals for 30-day mortality were 2.5-11.6% (point estimate 5.5%, 4.5% to 6.7%; 87 971) for TTAs and 4-26.6% (point estimate 10.9%, 8.3% to 14.2%; 42 145) for TFAs. Heterogeneity was high (> 75%) across all analyses.</p><p><strong>Conclusion: </strong>Most studies reporting short-term outcomes after major lower limb amputation are from high-income countries. Reported mortality is highly variable, but prediction intervals can be used to estimate mortality in future studies and inform shared decision-making.</p>","PeriodicalId":9028,"journal":{"name":"BJS Open","volume":"10 5","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13692688/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149262332","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Splenic hilum nodal involvement in resected left-sided pancreatic cancer: meta-analysis. 切除的左侧胰腺癌脾门淋巴结受累:荟萃分析。
IF 4.9 3区 医学
BJS Open Pub Date : 2026-09-04 DOI: 10.1093/bjsopen/zrag153
Caro L Bruna, Charlotte E Baggerman van Houweninge, Faridi S Jamaludin, Guiseppe Malleo, Mohammad Abu Hilal, Marc G Besselink, Jony van Hilst
{"title":"Splenic hilum nodal involvement in resected left-sided pancreatic cancer: meta-analysis.","authors":"Caro L Bruna, Charlotte E Baggerman van Houweninge, Faridi S Jamaludin, Guiseppe Malleo, Mohammad Abu Hilal, Marc G Besselink, Jony van Hilst","doi":"10.1093/bjsopen/zrag153","DOIUrl":"10.1093/bjsopen/zrag153","url":null,"abstract":"<p><strong>Background: </strong>Splenectomy is standard of care during left pancreatectomy for pancreatic ductal adenocarcinoma (PDAC) to obtain adequate lymphadenectomy. However, evidence supporting this approach is lacking. Splenic preservation would reduce short-term morbidity and is essential for emerging oncological adjunctive therapies, including immunotherapy and personalized cancer vaccines. This study reviewed the incidence of splenic hilum nodal involvement (SHNI) in left-sided PDAC.</p><p><strong>Methods: </strong>A systematic review of the PubMed, Embase, and Cochrane databases was performed, identifying studies published from inception to July 2026. Outcomes of interest were the rate of SHNI (station 10), overall survival, and the rate of splenic artery nodal involvement (SANI; station 11). Meta-analyses were conducted using random-effects models. Subgroup analyses for SHNI were performed per tumour localization (pancreatic neck, body, tail).</p><p><strong>Results: </strong>Among 2776 screened studies, 22 with 2260 patients undergoing left pancreatectomy for PDAC were included. The pooled prevalence of SHNI was 3.7% (95% confidence interval (c.i.) 2.2% to 6.2%); 1.1% for pancreatic body PDAC (95% c.i. 0.3% to 4.3%) and 9.7% for pancreatic tail PDAC (95% c.i. 3.5% to 24.0%). SHNI was not significantly associated with survival (pooled hazard ratio 2.05; 95% c.i. 0.89% to 4.72; P = 0.072). The pooled prevalence of SANI was 39.1% (95% c.i. 25.1% to 55.1%).</p><p><strong>Conclusion: </strong>In patients undergoing left pancreatectomy for PDAC, the presence of SHNI is rare, particularly in pancreatic body cancer (1.1%). These findings suggest that the relevance of routine splenectomy remains unclear, especially for pancreatic body PDAC. However, because the quality of current evidence is low, further investigation in prospective studies is required.</p>","PeriodicalId":9028,"journal":{"name":"BJS Open","volume":"10 5","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13563183/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148944357","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Familial adenomatous polyposis-associated desmoid disease: comprehensive review. 家族性腺瘤性息肉相关硬纤维瘤病:综合综述。
IF 4.9 3区 医学
BJS Open Pub Date : 2026-09-04 DOI: 10.1093/bjsopen/zrag089
Benjamin Zare, Susan Clark, Palma Dileo, David Liska, Andrew Latchford
{"title":"Familial adenomatous polyposis-associated desmoid disease: comprehensive review.","authors":"Benjamin Zare, Susan Clark, Palma Dileo, David Liska, Andrew Latchford","doi":"10.1093/bjsopen/zrag089","DOIUrl":"10.1093/bjsopen/zrag089","url":null,"abstract":"<p><strong>Background: </strong>Familial adenomatous polyposis (FAP)-associated desmoid disease is a rare but important manifestation of FAP and remains a major cause of morbidity and mortality. In contrast to sporadic desmoids, which most commonly occur in the abdominal wall or extra-abdominal sites, approximately 70% of FAP-associated desmoids arise intra-abdominally, usually within the small bowel mesentery. These lesions can cause bowel and ureteric obstruction, sepsis, intestinal failure, and death. This review summarizes current evidence regarding the pathogenesis, risk factors, diagnosis, surveillance, and management of FAP-associated desmoid disease, and identifies key evidence gaps.</p><p><strong>Methods: </strong>A literature search was performed in accordance with PRISMA methodology using Medline, Embase, PROSPERO, Cochrane, Campbell, and Joanna Briggs Institute databases. Original research studies, reviews, and guidelines relating to desmoid disease, FAP-associated desmoid disease, and FAP published up to August 2025 were eligible. Data were extracted and synthesized narratively by topic.</p><p><strong>Results: </strong>Aberrant Wnt/β-catenin signalling resulting from a germline APC pathogenic variant and a somatic second hit underpin the development of FAP-associated desmoid disease. Established risk factors include a distal APC pathogenic variant, positive family history, and previous abdominal surgery. Diagnosis in patients with established FAP is usually clinicoradiological, and routine biopsy is generally unnecessary, except in select circumstances. Active surveillance is now recommended as first-line management for most patients because many lesions remain stable or regress spontaneously. Surgery is primarily reserved for complications, particularly in small bowel mesenteric disease, owing to substantial operative morbidity and a lack of demonstrated survival benefit from complete resection. Systemic therapy is indicated for progressive or symptomatic disease. Tyrosine kinase inhibitors and the γ-secretase inhibitor nirogacestat have demonstrated efficacy in randomized trials, although patients with FAP-associated disease comprise only a small proportion of enrolled patients. Evidence supporting the use of non-steroidal anti-inflammatory drugs and anti-oestrogens remains limited.</p><p><strong>Conclusion: </strong>Important evidence gaps remain regarding optimal imaging strategies, predictors of aggressive disease, clinically meaningful trial endpoints, and FAP-specific treatment algorithms. Dedicated studies in genetically defined FAP cohorts are required to improve risk stratification and management.</p>","PeriodicalId":9028,"journal":{"name":"BJS Open","volume":"10 5","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13621219/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149073381","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书